Clinical application of tranexamic acid in arthroscopic rotator cuff repair surgery: A randomized controlled trial
Open Access
- 28 June 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (26) , e38515
Abstract
Background: To investigate whether intravenous administration of tranexamic acid (TXA) prior to arthroscopic rotator cuff repair improves operative blood loss, postoperative fibrinolytic index, inflammatory response, and postoperative pain. Methods: This was a prospective, double-blind, randomized controlled study. From January 2023 to February 2024, 64 patients who required arthroscopic rotator cuff repair were included and divided into tranexamic acid group (T group) group and control group (C group) according to the random number table method. In T group, 1000 mg TXA was administered intravenously 10 minutes before surgery, and an equivalent dose of normal saline was administered intravenously 10 minutes before surgery in C group. Intraoperative bleeding, postoperative fibrinolytic indexes, inflammatory indexes, pain scores, and occurrence of adverse effects were compared between the 2 groups. Results: Intraoperative bleeding in T group was lower than that in C group ( P < .05); D-D and FDP in T group were significantly lower than those in C group ( P < .05); postoperative TNF-α and IL-6 in 2 groups was higher than that before operation and T group was lower than C group ( P < .05); The pain scores of the 2 groups after operation were lower than those before operation ( P < .05), and there was no difference between the 2 groups ( P > .05). Conclusion subsections: TXA is able to reduce blood loss and inflammatory reactions, modulate fibrinolytic function, and promote postoperative recovery in patients undergoing arthroscopic rotator cuff repair, with no elevated risk of complications.Keywords
This publication has 30 references indexed in Scilit:
- Tranexamic Acid Use in Knee and Shoulder Arthroscopy Leads to Improved Outcomes and Fewer Hemarthrosis‐Related Complications: A Systematic Review of Level I and II StudiesArthroscopy, 2020
- Single Intravenous Administration of Tranexamic Acid in Anterior Cruciate Ligament Reconstruction to Reduce Postoperative Hemarthrosis and Increase Functional Outcomes in the Early Phase of Postoperative Rehabilitation: A Randomized Controlled TrialArthroscopy, 2019
- The Safety of Tranexamic Acid in Total Joint Arthroplasty: A Direct Meta-AnalysisThe Journal of Arthroplasty, 2018
- Tranexamic acid reduces blood loss after primary shoulder arthroplasty: a double-blind, placebo-controlled, prospective, randomized controlled trialJSES Open Access, 2018
- The efficacy and safety of multiple-dose intravenous tranexamic acid on blood loss following total knee arthroplasty: a randomized controlled trialInternational Orthopaedics, 2017
- Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysisWiener klinische Wochenschrift, 2017
- Diagnostic implication of fibrin degradation products and D-dimer in aortic dissectionScientific Reports, 2017
- Massive rotator cuff tears: pathomechanics, current treatment options, and clinical outcomesJournal of Shoulder and Elbow Surgery, 2015
- Distinct reactivity of the commercially available monoclonal antibodies of D-dimer and plasma FDP testing to the molecular variants of fibrin degradation productsThrombosis Research, 2013
- Long‐Term Outcome of Arthroscopic Massive Rotator Cuff Repair: The Importance of Double‐Row FixationArthroscopy, 2012